Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Female Contraceptive Market Growth 2022-2028

  • LP 4743241
  • 106 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Female Contraceptive will have significant change from previous year. According to our (LP Information) latest study, the global Female Contraceptive market size is USD million in 2022 from USD 17990 million in 2021, with a change of % between 2021 and 2022. The global Female Contraceptive market size will reach USD 21720 million in 2028, growing at a CAGR of 2.7% over the analysis period.

The United States Female Contraceptive market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Female Contraceptive market, reaching US$ million by the year 2028. As for the Europe Female Contraceptive landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Female Contraceptive players cover Merck, Pfizer, Allergan, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Female Contraceptive market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Female Contraceptive Devices

Female Contraceptive Drugs

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Online Stores

Retail Outlets

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck

Pfizer

Allergan

Bayer

Okamoto Industries

Reckitt Benckiser

Lupin Pharmaceuticals

Foundation Consumer Healthcare

Teva Pharmaceuticals

Ansell

Ferring Pharmaceuticals

Fuji Latex

Janssen Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Female Contraceptive Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Female Contraceptive by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Female Contraceptive by Country/Region, 2017, 2022 & 2028

2.2 Female Contraceptive Segment by Type

2.2.1 Female Contraceptive Devices

2.2.2 Female Contraceptive Drugs

2.3 Female Contraceptive Sales by Type

2.3.1 Global Female Contraceptive Sales Market Share by Type (2017-2022)

2.3.2 Global Female Contraceptive Revenue and Market Share by Type (2017-2022)

2.3.3 Global Female Contraceptive Sale Price by Type (2017-2022)

2.4 Female Contraceptive Segment by Application

2.4.1 Online Stores

2.4.2 Retail Outlets

2.5 Female Contraceptive Sales by Application

2.5.1 Global Female Contraceptive Sale Market Share by Application (2017-2022)

2.5.2 Global Female Contraceptive Revenue and Market Share by Application (2017-2022)

2.5.3 Global Female Contraceptive Sale Price by Application (2017-2022)

3 Global Female Contraceptive by Company

3.1 Global Female Contraceptive Breakdown Data by Company

3.1.1 Global Female Contraceptive Annual Sales by Company (2020-2022)

3.1.2 Global Female Contraceptive Sales Market Share by Company (2020-2022)

3.2 Global Female Contraceptive Annual Revenue by Company (2020-2022)

3.2.1 Global Female Contraceptive Revenue by Company (2020-2022)

3.2.2 Global Female Contraceptive Revenue Market Share by Company (2020-2022)

3.3 Global Female Contraceptive Sale Price by Company

3.4 Key Manufacturers Female Contraceptive Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Female Contraceptive Product Location Distribution

3.4.2 Players Female Contraceptive Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Female Contraceptive by Geographic Region

4.1 World Historic Female Contraceptive Market Size by Geographic Region (2017-2022)

4.1.1 Global Female Contraceptive Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Female Contraceptive Annual Revenue by Geographic Region

4.2 World Historic Female Contraceptive Market Size by Country/Region (2017-2022)

4.2.1 Global Female Contraceptive Annual Sales by Country/Region (2017-2022)

4.2.2 Global Female Contraceptive Annual Revenue by Country/Region

4.3 Americas Female Contraceptive Sales Growth

4.4 APAC Female Contraceptive Sales Growth

4.5 Europe Female Contraceptive Sales Growth

4.6 Middle East & Africa Female Contraceptive Sales Growth

5 Americas

5.1 Americas Female Contraceptive Sales by Country

5.1.1 Americas Female Contraceptive Sales by Country (2017-2022)

5.1.2 Americas Female Contraceptive Revenue by Country (2017-2022)

5.2 Americas Female Contraceptive Sales by Type

5.3 Americas Female Contraceptive Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Female Contraceptive Sales by Region

6.1.1 APAC Female Contraceptive Sales by Region (2017-2022)

6.1.2 APAC Female Contraceptive Revenue by Region (2017-2022)

6.2 APAC Female Contraceptive Sales by Type

6.3 APAC Female Contraceptive Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Female Contraceptive by Country

7.1.1 Europe Female Contraceptive Sales by Country (2017-2022)

7.1.2 Europe Female Contraceptive Revenue by Country (2017-2022)

7.2 Europe Female Contraceptive Sales by Type

7.3 Europe Female Contraceptive Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Female Contraceptive by Country

8.1.1 Middle East & Africa Female Contraceptive Sales by Country (2017-2022)

8.1.2 Middle East & Africa Female Contraceptive Revenue by Country (2017-2022)

8.2 Middle East & Africa Female Contraceptive Sales by Type

8.3 Middle East & Africa Female Contraceptive Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Female Contraceptive

10.3 Manufacturing Process Analysis of Female Contraceptive

10.4 Industry Chain Structure of Female Contraceptive

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Female Contraceptive Distributors

11.3 Female Contraceptive Customer

12 World Forecast Review for Female Contraceptive by Geographic Region

12.1 Global Female Contraceptive Market Size Forecast by Region

12.1.1 Global Female Contraceptive Forecast by Region (2023-2028)

12.1.2 Global Female Contraceptive Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Female Contraceptive Forecast by Type

12.7 Global Female Contraceptive Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Female Contraceptive Product Offered

13.1.3 Merck Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Female Contraceptive Product Offered

13.2.3 Pfizer Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Allergan

13.3.1 Allergan Company Information

13.3.2 Allergan Female Contraceptive Product Offered

13.3.3 Allergan Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Allergan Main Business Overview

13.3.5 Allergan Latest Developments

13.4 Bayer

13.4.1 Bayer Company Information

13.4.2 Bayer Female Contraceptive Product Offered

13.4.3 Bayer Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bayer Main Business Overview

13.4.5 Bayer Latest Developments

13.5 Okamoto Industries

13.5.1 Okamoto Industries Company Information

13.5.2 Okamoto Industries Female Contraceptive Product Offered

13.5.3 Okamoto Industries Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Okamoto Industries Main Business Overview

13.5.5 Okamoto Industries Latest Developments

13.6 Reckitt Benckiser

13.6.1 Reckitt Benckiser Company Information

13.6.2 Reckitt Benckiser Female Contraceptive Product Offered

13.6.3 Reckitt Benckiser Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Reckitt Benckiser Main Business Overview

13.6.5 Reckitt Benckiser Latest Developments

13.7 Lupin Pharmaceuticals

13.7.1 Lupin Pharmaceuticals Company Information

13.7.2 Lupin Pharmaceuticals Female Contraceptive Product Offered

13.7.3 Lupin Pharmaceuticals Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Lupin Pharmaceuticals Main Business Overview

13.7.5 Lupin Pharmaceuticals Latest Developments

13.8 Foundation Consumer Healthcare

13.8.1 Foundation Consumer Healthcare Company Information

13.8.2 Foundation Consumer Healthcare Female Contraceptive Product Offered

13.8.3 Foundation Consumer Healthcare Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Foundation Consumer Healthcare Main Business Overview

13.8.5 Foundation Consumer Healthcare Latest Developments

13.9 Teva Pharmaceuticals

13.9.1 Teva Pharmaceuticals Company Information

13.9.2 Teva Pharmaceuticals Female Contraceptive Product Offered

13.9.3 Teva Pharmaceuticals Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Teva Pharmaceuticals Main Business Overview

13.9.5 Teva Pharmaceuticals Latest Developments

13.10 Ansell

13.10.1 Ansell Company Information

13.10.2 Ansell Female Contraceptive Product Offered

13.10.3 Ansell Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Ansell Main Business Overview

13.10.5 Ansell Latest Developments

13.11 Ferring Pharmaceuticals

13.11.1 Ferring Pharmaceuticals Company Information

13.11.2 Ferring Pharmaceuticals Female Contraceptive Product Offered

13.11.3 Ferring Pharmaceuticals Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Ferring Pharmaceuticals Main Business Overview

13.11.5 Ferring Pharmaceuticals Latest Developments

13.12 Fuji Latex

13.12.1 Fuji Latex Company Information

13.12.2 Fuji Latex Female Contraceptive Product Offered

13.12.3 Fuji Latex Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Fuji Latex Main Business Overview

13.12.5 Fuji Latex Latest Developments

13.13 Janssen Pharmaceuticals

13.13.1 Janssen Pharmaceuticals Company Information

13.13.2 Janssen Pharmaceuticals Female Contraceptive Product Offered

13.13.3 Janssen Pharmaceuticals Female Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Janssen Pharmaceuticals Main Business Overview

13.13.5 Janssen Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Female Contraceptive Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Female Contraceptive Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Female Contraceptive Devices

Table 4. Major Players of Female Contraceptive Drugs

Table 5. Global Female Contraceptive Sales by Type (2017-2022) & (K Units)

Table 6. Global Female Contraceptive Sales Market Share by Type (2017-2022)

Table 7. Global Female Contraceptive Revenue by Type (2017-2022) & ($ million)

Table 8. Global Female Contraceptive Revenue Market Share by Type (2017-2022)

Table 9. Global Female Contraceptive Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Female Contraceptive Sales by Application (2017-2022) & (K Units)

Table 11. Global Female Contraceptive Sales Market Share by Application (2017-2022)

Table 12. Global Female Contraceptive Revenue by Application (2017-2022)

Table 13. Global Female Contraceptive Revenue Market Share by Application (2017-2022)

Table 14. Global Female Contraceptive Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Female Contraceptive Sales by Company (2020-2022) & (K Units)

Table 16. Global Female Contraceptive Sales Market Share by Company (2020-2022)

Table 17. Global Female Contraceptive Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Female Contraceptive Revenue Market Share by Company (2020-2022)

Table 19. Global Female Contraceptive Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Female Contraceptive Producing Area Distribution and Sales Area

Table 21. Players Female Contraceptive Products Offered

Table 22. Female Contraceptive Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Female Contraceptive Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Female Contraceptive Sales Market Share Geographic Region (2017-2022)

Table 27. Global Female Contraceptive Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Female Contraceptive Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Female Contraceptive Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Female Contraceptive Sales Market Share by Country/Region (2017-2022)

Table 31. Global Female Contraceptive Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Female Contraceptive Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Female Contraceptive Sales by Country (2017-2022) & (K Units)

Table 34. Americas Female Contraceptive Sales Market Share by Country (2017-2022)

Table 35. Americas Female Contraceptive Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Female Contraceptive Revenue Market Share by Country (2017-2022)

Table 37. Americas Female Contraceptive Sales by Type (2017-2022) & (K Units)

Table 38. Americas Female Contraceptive Sales Market Share by Type (2017-2022)

Table 39. Americas Female Contraceptive Sales by Application (2017-2022) & (K Units)

Table 40. Americas Female Contraceptive Sales Market Share by Application (2017-2022)

Table 41. APAC Female Contraceptive Sales by Region (2017-2022) & (K Units)

Table 42. APAC Female Contraceptive Sales Market Share by Region (2017-2022)

Table 43. APAC Female Contraceptive Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Female Contraceptive Revenue Market Share by Region (2017-2022)

Table 45. APAC Female Contraceptive Sales by Type (2017-2022) & (K Units)

Table 46. APAC Female Contraceptive Sales Market Share by Type (2017-2022)

Table 47. APAC Female Contraceptive Sales by Application (2017-2022) & (K Units)

Table 48. APAC Female Contraceptive Sales Market Share by Application (2017-2022)

Table 49. Europe Female Contraceptive Sales by Country (2017-2022) & (K Units)

Table 50. Europe Female Contraceptive Sales Market Share by Country (2017-2022)

Table 51. Europe Female Contraceptive Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Female Contraceptive Revenue Market Share by Country (2017-2022)

Table 53. Europe Female Contraceptive Sales by Type (2017-2022) & (K Units)

Table 54. Europe Female Contraceptive Sales Market Share by Type (2017-2022)

Table 55. Europe Female Contraceptive Sales by Application (2017-2022) & (K Units)

Table 56. Europe Female Contraceptive Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Female Contraceptive Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Female Contraceptive Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Female Contraceptive Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Female Contraceptive Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Female Contraceptive Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Female Contraceptive Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Female Contraceptive Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Female Contraceptive Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Female Contraceptive

Table 66. Key Market Challenges & Risks of Female Contraceptive

Table 67. Key Industry Trends of Female Contraceptive

Table 68. Female Contraceptive Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Female Contraceptive Distributors List

Table 71. Female Contraceptive Customer List

Table 72. Global Female Contraceptive Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Female Contraceptive Sales Market Forecast by Region

Table 74. Global Female Contraceptive Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Female Contraceptive Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Female Contraceptive Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Female Contraceptive Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Female Contraceptive Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Female Contraceptive Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Female Contraceptive Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Female Contraceptive Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Female Contraceptive Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Female Contraceptive Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Female Contraceptive Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Female Contraceptive Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Female Contraceptive Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Female Contraceptive Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Female Contraceptive Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Female Contraceptive Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Female Contraceptive Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Female Contraceptive Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Female Contraceptive Product Offered

Table 94. Merck Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. Pfizer Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 98. Pfizer Female Contraceptive Product Offered

Table 99. Pfizer Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Pfizer Main Business

Table 101. Pfizer Latest Developments

Table 102. Allergan Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 103. Allergan Female Contraceptive Product Offered

Table 104. Allergan Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Allergan Main Business

Table 106. Allergan Latest Developments

Table 107. Bayer Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 108. Bayer Female Contraceptive Product Offered

Table 109. Bayer Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Bayer Main Business

Table 111. Bayer Latest Developments

Table 112. Okamoto Industries Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 113. Okamoto Industries Female Contraceptive Product Offered

Table 114. Okamoto Industries Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Okamoto Industries Main Business

Table 116. Okamoto Industries Latest Developments

Table 117. Reckitt Benckiser Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 118. Reckitt Benckiser Female Contraceptive Product Offered

Table 119. Reckitt Benckiser Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Reckitt Benckiser Main Business

Table 121. Reckitt Benckiser Latest Developments

Table 122. Lupin Pharmaceuticals Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 123. Lupin Pharmaceuticals Female Contraceptive Product Offered

Table 124. Lupin Pharmaceuticals Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Lupin Pharmaceuticals Main Business

Table 126. Lupin Pharmaceuticals Latest Developments

Table 127. Foundation Consumer Healthcare Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 128. Foundation Consumer Healthcare Female Contraceptive Product Offered

Table 129. Foundation Consumer Healthcare Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Foundation Consumer Healthcare Main Business

Table 131. Foundation Consumer Healthcare Latest Developments

Table 132. Teva Pharmaceuticals Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 133. Teva Pharmaceuticals Female Contraceptive Product Offered

Table 134. Teva Pharmaceuticals Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Teva Pharmaceuticals Main Business

Table 136. Teva Pharmaceuticals Latest Developments

Table 137. Ansell Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 138. Ansell Female Contraceptive Product Offered

Table 139. Ansell Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Ansell Main Business

Table 141. Ansell Latest Developments

Table 142. Ferring Pharmaceuticals Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 143. Ferring Pharmaceuticals Female Contraceptive Product Offered

Table 144. Ferring Pharmaceuticals Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Ferring Pharmaceuticals Main Business

Table 146. Ferring Pharmaceuticals Latest Developments

Table 147. Fuji Latex Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 148. Fuji Latex Female Contraceptive Product Offered

Table 149. Fuji Latex Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Fuji Latex Main Business

Table 151. Fuji Latex Latest Developments

Table 152. Janssen Pharmaceuticals Basic Information, Female Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 153. Janssen Pharmaceuticals Female Contraceptive Product Offered

Table 154. Janssen Pharmaceuticals Female Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Janssen Pharmaceuticals Main Business

Table 156. Janssen Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Female Contraceptive

Figure 2. Female Contraceptive Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Female Contraceptive Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Female Contraceptive Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Female Contraceptive Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Female Contraceptive Devices

Figure 10. Product Picture of Female Contraceptive Drugs

Figure 11. Global Female Contraceptive Sales Market Share by Type in 2021

Figure 12. Global Female Contraceptive Revenue Market Share by Type (2017-2022)

Figure 13. Female Contraceptive Consumed in Online Stores

Figure 14. Global Female Contraceptive Market: Online Stores (2017-2022) & (K Units)

Figure 15. Female Contraceptive Consumed in Retail Outlets

Figure 16. Global Female Contraceptive Market: Retail Outlets (2017-2022) & (K Units)

Figure 17. Global Female Contraceptive Sales Market Share by Application (2017-2022)

Figure 18. Global Female Contraceptive Revenue Market Share by Application in 2021

Figure 19. Female Contraceptive Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Female Contraceptive Revenue Market Share by Company in 2021

Figure 21. Global Female Contraceptive Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Female Contraceptive Revenue Market Share by Geographic Region in 2021

Figure 23. Global Female Contraceptive Sales Market Share by Region (2017-2022)

Figure 24. Global Female Contraceptive Revenue Market Share by Country/Region in 2021

Figure 25. Americas Female Contraceptive Sales 2017-2022 (K Units)

Figure 26. Americas Female Contraceptive Revenue 2017-2022 ($ Millions)

Figure 27. APAC Female Contraceptive Sales 2017-2022 (K Units)

Figure 28. APAC Female Contraceptive Revenue 2017-2022 ($ Millions)

Figure 29. Europe Female Contraceptive Sales 2017-2022 (K Units)

Figure 30. Europe Female Contraceptive Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Female Contraceptive Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Female Contraceptive Revenue 2017-2022 ($ Millions)

Figure 33. Americas Female Contraceptive Sales Market Share by Country in 2021

Figure 34. Americas Female Contraceptive Revenue Market Share by Country in 2021

Figure 35. United States Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Female Contraceptive Sales Market Share by Region in 2021

Figure 40. APAC Female Contraceptive Revenue Market Share by Regions in 2021

Figure 41. China Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Female Contraceptive Sales Market Share by Country in 2021

Figure 48. Europe Female Contraceptive Revenue Market Share by Country in 2021

Figure 49. Germany Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Female Contraceptive Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Female Contraceptive Revenue Market Share by Country in 2021

Figure 56. Egypt Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Female Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Female Contraceptive in 2021

Figure 62. Manufacturing Process Analysis of Female Contraceptive

Figure 63. Industry Chain Structure of Female Contraceptive

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390